The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Treatment of ADHD in children with tics: A randomized controlled trial
Abstract
BACKGROUND: The treatment of children with attention deficit hyperactivity disorder (ADHD) and Tourette syndrome (TS) has been problematic because methylphenidate (MPH)--the most commonly used drug to treat ADHD--has been reported to worsen tics and because clonidine (CLON)--the most commonly prescribed alternative--has unproven efficacy. METHODS: The authors conducted a multicenter, randomized, double-blind clinical trial in which 136 children with ADHD and a chronic tic disorder were randomly administered CLON alone, MPH alone, combined CLON + MPH, or placebo (2 x 2 factorial design). Each subject participated for 16 weeks (weeks 1-4 CLON/placebo dose titration, weeks 5-8 added MPH/placebo dose titration, weeks 9-16 maintenance therapy). RESULTS: Thirty-seven children were administered MPH alone, 34 were administered CLON alone, 33 were administered CLON + MPH, and 32 were administered placebo. For our primary outcome measure of ADHD (Conners Abbreviated Symptom Questionnaire--Teacher), significant improvement occurred for subjects assigned to CLON (p < 0.002) and those assigned to MPH (p < 0.003). Compared with placebo, the greatest benefit occurred with combined CLON + MPH (p < 0.0001). CLON appeared to be most helpful for impulsivity and hyperactivity; MPH appeared to be most helpful for inattention. The proportion of individual subjects reporting a worsening of tics as an adverse effect was no higher in those treated with MPH (20%) than those being administered CLON alone (26%) or placebo (22%). Compared with placebo, measured tic severity lessened in all active treatment groups in the following order: CLON + MPH, CLON alone, MPH alone. Sedation was common with CLON treatment (28% reported moderate or severe sedation), but otherwise the drugs were tolerated well, including absence of any evident cardiac toxicity. CONCLUSIONS: Methylphenidate and clonidine (particularly in combination) are effective for ADHD in children with comorbid tics. Prior recommendations to avoid methylphenidate in these children because of concerns of worsening tics are unsupported by this trial.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For clonidine, which is only occasionally used in Europe to treat TD and/or ADHD, but recommended by some authors (especially where TD is the predominant disorder) [116], there exists some evidence that it may reduce tics in frequency and severity, as well as improve ADHD symptoms; but on the other hand, worsening of tics may be seen in about a quarter of cases [3].”
From European guidelines on managing adverse effects of medication for ADHD (2011) · cites this paper as [3]
Citations
Cites
The Yale-Brown Obsessive Compulsive Scale: I. Development, Use, and Reliability
Goodman, W. K. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810110048007 · Cited by 7,712
A Children's Global Assessment Scale (CGAS)
Shaffer, D. (1983) · Archives of General Psychiatry · doi:10.1001/archpsyc.1983.01790100074010 · Cited by 3,716
Normative data on Revised Conners Parent and Teacher Rating Scales
Goyette, C. H., Conners, C. K., & Ulrich, R. F. (1978) · Research on Child and Adolescent Psychopathology · doi:10.1007/bf00919127 · Cited by 1,728
Teacher Ratings of DSM-III-R Symptoms for the Disruptive Behavior Disorders
Pelham, W. E., Gnagy, E. M., Greenslade, K. E., & Milich, R. S. (1992) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199203000-00006 · Cited by 1,315
Scahill, L., Chappell, P. B., Kim, Y. S., Schultz, R. T., Katsovich, L., Shepherd, E., Arnsten, A. F. T., Cohen, D. J., & Leckman, J. F. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.7.1067 · Cited by 588
Clonidine Treatment of Gilles de la Tourette's Syndrome
Leckman, J. F. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810280040006 · Cited by 334
An Open Trial of Guanfacine in the Treatment of Attention-Deficit Hyperactivity Disorder
Hunt, R. D., Arnsten, A. F. T., & Asbell, M. D. (1995) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199501000-00013 · Cited by 308
Effect of Stimulant Medication on Children with Attention Deficit Disorder: A “Review of Reviews”
Swanson, J. M., McBurnett, K., Wigal, T. L., Pfiffner, L. J., Lerner, M., Williams, L., Christian, D. L., Tamm, L., Willcutt, E. G., Crowley, K., et al. (1993) · Exceptional Children · doi:10.1177/001440299306000209 · Cited by 305
Stimulant Medications Precipitate Tourette's Syndrome
Lowe, T. L. (1982) · JAMA · doi:10.1001/jama.1982.03320370043028 · Cited by 256
Fisher, P. W., Shaffer, D. R., Piacentini, J. C., Lapkin, J. B., Kafantaris, V., Leonard, H., & Herzog, D. B. (1993) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199305000-00026 · Cited by 251
Research works printed but not linked: 7
- Walkup JT Khan S Schuerholz L et al. Phenomenology and natural history of tic-related ADHD and learning disabilities. In: Leckman JF Cohen DJ eds. Tourette’s syndrome: tics obsessions compulsions. New York: Wiley 1999; 63–79.
- Kurlan R Trinidad KS. Treatment of tics. In: Kurlan R ed. The Treatment of Movement Disorders. Philadelphia: JB Lippincott 1995; 365–406.
- Tanner JM. Growth in adolescence 2nd ed. Oxford: Blackwell Scientific 1962.
- Atkins MS Pelham WE Licht MH. The development and validation of objective classroom measures for conduct and attention deficit disorders. In: Prinz R ed. Advances in behavioral assessment of children and families Vol 4. Greenwich CT: JAI Press 1988; 3–33.
- Leckman JF Towbin KE Ort SI Cohen DJ. Clinical assessment of tic disorder severity. In: Cohen DJ Bruun RD Leckman JF eds. Tourette’s syndrome and tic disorders. New York: Wiley 1988: 55–78.
- Scahill L King RA Schultz RT Leckman JF. Selection and use of diagnostic and clinical rating instruments. In: Leckman JF Cohen DJ eds. Tourette’s syndrome tics obsessions compulsions: development psychopathology and clinical care. New York: John Wiley and Sons 1998; 310–324.
- Conners CK, Barkley RA. Rating scales and checklists for psychopharmacologic trials. Psychopharm Bull . 1985; 21: 809–854.
Cited by
Sorted by citations
Items 101–200 of 507
Ching, C., Eslick, G. D., & Poulton, A. S. (2019) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2019.0905 · Cited by 70
First-onset tics in patients with attention-deficit–hyperactivity disorder: impact of stimulants
Roessner, V., Robatzek, M., Knapp, G., Banaschewski, T., & Rothenberger, A. (2006) · Developmental Medicine & Child Neurology · doi:10.1017/s0012162206001290 · Cited by 70
Tics in the Pediatric Population: Pragmatic Management
Ganos, C., Martino, D., & Pringsheim, T. M. (2016) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.12428 · Cited by 71
Tics and Tourette: a clinical, pathophysiological and etiological review
Dale, R. C. (2017) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000000546 · Cited by 70
Shier, A. C., Reichenbacher, T., Ghuman, H. S., & GHUMAN, J. K. (2012) · Journal of Central Nervous System Disease · doi:10.4137/jcnsd.s6691 · Cited by 79
Emergence of Tics in Children with ADHD: Impact of Once-Daily OROS® Methylphenidate Therapy
Palumbo, D., Spencer, T., Lynch, J., Co-Chien, H., & Faraone, S. V. (2004) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/1044546041649138 · Cited by 67
Gilles de la Tourette syndrome as a paradigmatic neuropsychiatric disorder
Cavanna, A. E. (2018) · CNS Spectrums · doi:10.1017/s1092852918000834 · Cited by 69
Emerging treatments for Tourette’s disorder
Bloch, M. H. (2008) · Current Psychiatry Reports · doi:10.1007/s11920-008-0052-z · Cited by 67
Swerdlow, N. R. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.09.002 · Cited by 72
Tics and stereotypies: A comparative clinical review
Martino, D., & Hedderly, T. J. (2019) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2019.02.005 · Cited by 66
Tic disorders: from pathophysiology to treatment
Rampello, L., Alvano, A., Battaglia, G., Bruno, V., Raffaele, R., & Nicoletti, F. (2005) · Journal of Neurology · doi:10.1007/s00415-005-0008-8 · Cited by 66
Tourette Syndrome and Other Tic Disorders in Childhood, Adolescence and Adulthood
Ludolph, A. G., Roessner, V., Münchau, A. M., & Müller‐Vahl, K. (2012) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2012.0821 · Cited by 68
Tourette disorder and other tic disorders
Deeb, W., Malaty, I. A., & Mathews, C. A. (2019) · Handbook of clinical neurology · doi:10.1016/b978-0-444-64012-3.00008-3 · Cited by 67
Mueller, S. G., Laxer, K. D., Schuff, N. W., & Weiner, M. W. (2007) · Epilepsia · doi:10.1111/j.1528-1167.2006.00916.x · Cited by 65
Sallee, F. R., Connor, D. F., & Newcorn, J. H. (2013) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2013.0028 · Cited by 64
Comorbidities of epilepsy in low and middle-income countries: systematic review and meta-analysis
Aline, M., Preux, P., Gérard, D., Marin, B., Boumédiène, F., Ntamwira, C., & Tsai, C.-H. (2020) · Scientific Reports · doi:10.1038/s41598-020-65768-6 · Cited by 63
Tic disorders: some key issues for DSM-V
Walkup, J. T., Ferrão, Y. A., Leckman, J. F., Stein, D. J., & Singer, H. S. (2010) · Depression and Anxiety · doi:10.1002/da.20711 · Cited by 63
Attention-Deficit Hyperactivity Disorder
MAY, D. E., & Kratochvil, C. J. (2009) · Drugs · doi:10.2165/11530540-000000000-00000 · Cited by 62
Non-stimulant treatment for Attention-Deficit/Hyperactivity Disorder
Spencer, T. J., & Biederman, J. (2002) · Journal of Attention Disorders · doi:10.1177/070674370200601s13 · Cited by 62
Psychopharmacological Interventions
Biederman, J., & Spencer, T. J. (2008) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2007.12.001 · Cited by 62
ADHD in Children, Adolescents, and Adults
Katragadda, S., & Schubiner, H. (2007) · Primary Care: Clinics in Office Practice · doi:10.1016/j.pop.2007.04.012 · Cited by 61
The Role of Atypical Antipsychotics for Treatment of Tourette’s Syndrome: An Overview
Budman, C. L. (2014) · Drugs · doi:10.1007/s40265-014-0254-0 · Cited by 63
Tourette syndrome and other chronic tic disorders: an update on clinical management
Martino, D., & Pringsheim, T. M. (2017) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2018.1413938 · Cited by 59
Alpha-2 adrenergic agonists in children with inattention, hyperactivity and impulsiveness
Scahill, L. (2009) · CNS Drugs · doi:10.2165/00023210-200923000-00006 · Cited by 58
Using animal models to develop therapeutics for Tourette Syndrome
Swerdlow, N. R., & Sutherland, A. N. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.05.003 · Cited by 60
Research in child and adolescent psychopharmacology: recent accomplishments and new challenges
Vitiello, B. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0414-3 · Cited by 58
Dooley, J. M. (2006) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2006.09.004 · Cited by 57
McCracken, J. T., McGough, J. J., Loo, S. K., Levitt, J., Del’Homme, M., Cowen, J., Sturm, A., Whelan, F., Hellemann, G., Sugar, C., et al. (2016) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2016.05.015 · Cited by 57
Clinical Pharmacology of Dopamine-Modulating Agents in Tourette’s Syndrome
Mogwitz, S., Buse, J., Ehrlich, S., & Roessner, V. (2013) · International review of neurobiology · doi:10.1016/b978-0-12-411546-0.00010-x · Cited by 57
Guanfacine Extended Release: A New Pharmacological Treatment Option in Europe
Huß, M., Chen, W., & Ludolph, A. G. (2015) · Clinical Drug Investigation · doi:10.1007/s40261-015-0336-0 · Cited by 60
Ruggiero, S., Clavenna, A., Reale, L., Capuano, A., Rossi, F., & Bonati, M. R. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.08.001 · Cited by 55
Drug-induced Movement Disorders
Mehta, S. H., Morgan, J. C., & Sethi, K. D. (2014) · Neurologic Clinics · doi:10.1016/j.ncl.2014.09.011 · Cited by 55
Neurosurgical treatment for Gilles de la Tourette syndrome: The Italian perspective
Porta, M., Sassi, M., Ali, F., Cavanna, A. E., & Servello, D. (2009) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2009.06.001 · Cited by 53
Gadow, K. D., Nolan, E. E., Sverd, J., Sprafkin, J., & Schneider, J. (2008) · Journal of Child Neurology · doi:10.1177/0883073808315412 · Cited by 49
Cavanna, A. E., & Termine, C. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-0653-2_28 · Cited by 49
Sukhodolsky, D. G., Leckman, J. F., Rothenberger, A., & Scahill, L. D. (2007) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-007-1007-3 · Cited by 49
Treatment of tics associated with Tourette syndrome
Jankovic, J. J. (2020) · Journal of Neural Transmission · doi:10.1007/s00702-019-02105-w · Cited by 49
Movement Disorders Emergencies Part 2
Robottom, B., Factor, S. A., & Weiner, W. J. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.117 · Cited by 49
Bhatara, V. S., FEIL, M., Hoagwood, K., Vitiello, B., & Zima, B. T. (2004) · Journal of Attention Disorders · doi:10.1177/108705470400700404 · Cited by 48
Movement Disorders in Children
Schlaggar, B. L., & Mink, J. W. (2003) · Pediatrics in Review · doi:10.1542/pir.24-2-39 · Cited by 47
Groenman, A. P., Schweren, L. J. S., Dietrich, A., & Hoekstra, P. J. (2017) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2017.1301928 · Cited by 46
Clinical Correlates and Mediators of Self-Concept in Youth with Chronic Tic Disorders
Hanks, C. E., Mcguire, J. F., Lewin, A. B., Storch, E. A., & Murphy, T. K. (2015) · Child Psychiatry & Human Development · doi:10.1007/s10578-015-0544-0 · Cited by 48
Psychopharmacological Treatment of Oppositional Defiant Disorder
Turgay, A. (2008) · CNS Drugs · doi:10.2165/0023210-200923010-00001 · Cited by 46
Tourette Syndrome Treatment Updates: a Review and Discussion of the Current and Upcoming Literature
Frey, J., & Malaty, I. A. (2022) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-022-01177-8 · Cited by 45
Lyon, G. J., Samar, S. M., Conelea, C. A., Trujillo, M. R., Lipinski, C. M., Bauer, C. C., Brandt, B. C., Kemp, J. J., Lawrence, Z. E., Howard, J., et al. (2010) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2010.0032 · Cited by 45
Diagnosis and Management of Depression and Psychosis in Children and Adolescents With Epilepsy
Kanner, A. M., & Dunn, D. W. (2004) · Journal of Child Neurology · doi:10.1177/088307380401900108 · Cited by 45
Nubukpo, P., Preux, P., Houinato, D. S., Radji, A., Grunitzky, E. K., Avodé, G., & Clément, J. (2004) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2004.07.001 · Cited by 45
Patterns and Correlates of Tic Disorder Diagnoses in Privately and Publicly Insured Youth
Olfson, M., Crystal, S., Gerhard, T., Huang, C., Walkup, J. T., Scahill, L. D., & Walkup, J. T. (2011) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2010.11.009 · Cited by 44
Malone, R. P., Gratz, S. S., Delaney, M. A., & Hyman, S. L. (2005) · CNS Drugs · doi:10.2165/00023210-200519110-00003 · Cited by 45
A DSM-IV—Referenced Teacher Rating Scale for Use in Clinical Management
Mattison, R. E., Gadow, K. D., Sprafkin, J. N., Nolan, E. E., & Schneider, J. (2003) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000046813.95464.b3 · Cited by 43
Pharmacological treatment of Tourette syndrome
Gilbert, D. L., & Jankovic, J. J. (2014) · Journal of Obsessive-Compulsive and Related Disorders · doi:10.1016/j.jocrd.2014.04.006 · Cited by 44
Metabolic, toxicological, and safety considerations for drugs used to treat ADHD
Duong, S., Chung, K., & Wigal, S. B. (2012) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2012.671295 · Cited by 42
Masi, G., Gagliano, A., Siracusano, R., Berloffa, S., Calarese, T., Ilardo, G., Pfanner, C., Magazù, A., & Cedro, C. (2012) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2011.0081 · Cited by 41
Evidence-based treatment of Tourette’s disorder and chronic tic disorders
Essoe, J. K.-Y., Grados, M. A., Singer, H. S., Myers, N. S., & Mcguire, J. F. (2019) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2019.1643236 · Cited by 41
Pharmacodynamics of Ziprasidone in Children and Adolescents: Impact on Dopamine Transmission
Sallee, F. R., Gilbert, D. L., Vinks, A. A. T. M. M., Miceli, J. J., Robarge, L., & Wilner, K. D. (2003) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000046897.27264.46 · Cited by 41
Methylphenidate HCl: therapy for attention deficit hyperactivity disorder
Capp, P. K., Pearl, P. L., & Conlon, C. J. (2005) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.5.3.325 · Cited by 42
Managing attention deficit/hyperactivity disorder: unmet needs and future directions
Steer, C. (2005) · Archives of Disease in Childhood · doi:10.1136/adc.2004.059352 · Cited by 42
Atomoxetine Use Associated with Onset of a Motor Tic
Ledbetter, M. (2005) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2005.15.331 · Cited by 40
Serajee, F., & Huq, A. H. M. M. (2015) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2015.03.007 · Cited by 40
Katzman, M. A., & Sternat, T. (2014) · CNS Drugs · doi:10.1007/s40263-014-0175-1 · Cited by 40
Jureidini, J. N., Tonkin, A., & Jureidini, E. (2013) · Pediatric Drugs · doi:10.1007/s40272-013-0032-6 · Cited by 40
A Review of the Current Treatment of Tourette Syndrome
Seideman, M. F., & Seideman, T. A. (2020) · The Journal of Pediatric Pharmacology and Therapeutics · doi:10.5863/1551-6776-25.5.401 · Cited by 40
Methylphenidate for the Treatment of Parkinson Disease and Other Neurological Disorders
Auriel, E., Hausdorff, J. M., & Giladi, N. (2008) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e318170576c · Cited by 40
Pandey, S., & Dash, D. (2019) · The Neurologist · doi:10.1097/nrl.0000000000000218 · Cited by 39
Simpson, H. A., Jung, L., & Murphy, T. K. (2011) · Current Psychiatry Reports · doi:10.1007/s11920-011-0223-1 · Cited by 39
Ferrín, M., & Taylor, E. A. (2011) · Future Neurology · doi:10.2217/fnl.11.5 · Cited by 42
Neuropsychological Effects of Stimulant Medication on Children’s Learning and Behavior
Brown, R. T., & Borden, K. A. (1989) · Critical issues in neuropsychology · doi:10.1007/978-1-4899-6807-4_24 · Cited by 39
Ecopipam for Tourette Syndrome: A Randomized Trial
Gilbert, D. L., Dubow, J. S., Cunniff, T. M., Wanaski, S. P., Atkinson, S. D., & Mahableshwarkar, A. R. (2023) · PEDIATRICS · doi:10.1542/peds.2022-059574 · Cited by 38
Tourette’s syndrome: Are stimulants safe?
Kurlan, R. (2003) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-003-0004-2 · Cited by 38
Drug and non-drug treatments of children with ADHD and tic disorders
Poncin, Y., Sukhodolsky, D. G., McGuire, J., & Scahill, L. (2007) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-007-1010-8 · Cited by 37
The Potential of Cannabinoid-Based Treatments in Tourette Syndrome
Artukoglu, B. B., & Bloch, M. H. (2019) · CNS Drugs · doi:10.1007/s40263-019-00627-1 · Cited by 39
Epilepsy and Attention Deficit Hyperactivity Disorder: Connection, Chance, and Challenges
Fan, H., Chiang, K.-L., Chang, K., Chen, C., & Tsai, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065270 · Cited by 39
Tsujii, N., Usami, M., Naya, N., Tsuji, T., Mishima, H., Horie, J., Fujiwara, M., & Iida, J. (2021) · Neurology and Therapy · doi:10.1007/s40120-021-00249-0 · Cited by 36
Ming, S. X., Mulvey, Mohanty, & Patel (2011) · Adolescent Health Medicine and Therapeutics · doi:10.2147/ahmt.s15672 · Cited by 36
Randomised Controlled Study-efficacy of Clonidine versus Carbamazepine in Children with ADHD
Nair, V., & Mahadevan, S. (2008) · Journal of Tropical Pediatrics · doi:10.1093/tropej/fmn117 · Cited by 36
Roessner, V., Banaschewski, T., & Rothenberger, A. (2004) · Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie · doi:10.1024/1422-4917.32.4.245 · Cited by 36
Distribution of the Noradrenaline Innervation and Adrenoceptors in the Macaque Monkey Thalamus
Pérez-Santos, I., Palomero‐Gallagher, N., Zilles, K., & Cavada, C. (2021) · Cerebral Cortex · doi:10.1093/cercor/bhab073 · Cited by 39
Párraga, H. C., Párraga, M. I., & Harris, D. K. (2007) · The International Journal of Psychiatry in Medicine · doi:10.2190/pm.37.4.e · Cited by 34
Fitzgerald, P. J. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1856-1 · Cited by 36
Oluwabusi, O. O. (2016) · World Journal of Clinical Pediatrics · doi:10.5409/wjcp.v5.i1.128 · Cited by 33
Cingulate role in Tourette syndrome
O’Neill, J., Piacentini, J. C., & Peterson, B. S. (2019) · Handbook of clinical neurology · doi:10.1016/b978-0-444-64196-0.00011-x · Cited by 32
Drug‐induced Movement Disorders in Children
Gilbert, D. L. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1444.005 · Cited by 32
Updates in Medical and Surgical Therapies for Tourette Syndrome
Malaty, I. A., & Akbar, U. (2014) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-014-0458-4 · Cited by 31
Shaw, Z. A., & Coffey, B. J. (2014) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2014.05.001 · Cited by 31
Correlates and Clinical Implications of Tic Suppressibility
Ueda, K., Kim, S., Greene, D. J., & BLACK, K. J. (2021) · Current Developmental Disorders Reports · doi:10.1007/s40474-021-00230-4 · Cited by 31
Besag, F., Vasey, M. J., Lao, K. S. J., Chowdhury, U., & Stern, J. S. (2021) · Journal of Psychopharmacology · doi:10.1177/02698811211032445 · Cited by 31
The treatment of severe child aggression (TOSCA) study: Design challenges
Farmer, C., Arnold, L. E., Bukstein, O. G., Findling, R. L., Gadow, K. D., Li, X., Butter, E. M., & Aman, M. G. (2011) · Child and Adolescent Psychiatry and Mental Health · doi:10.1186/1753-2000-5-36 · Cited by 30
Attention-deficit/hyperactivity disorder in children and adolescents
Dunn, D. W., & Kronenberger, W. G. (2003) · Neurologic Clinics · doi:10.1016/s0733-8619(03)00009-4 · Cited by 30
The treatment of Tourette’s syndrome: current opinions
Müller‐Vahl, K. (2002) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.3.7.899 · Cited by 30
Nonstimulant Treatments for ADHD
Newcorn, J. H., Krone, B., & Dittmann, R. W. (2022) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2022.03.005 · Cited by 29
Clinical characteristics of adult patients with tics and/or Tourette's syndrome
Ohta, M., & Kano, Y. (2003) · Brain and Development · doi:10.1016/s0387-7604(03)90006-4 · Cited by 29
Clinical Pharmacology of Comorbid Attention Deficit Hyperactivity Disorder in Tourette Syndrome
Rizzo, R., & Gulisano, M. (2013) · International review of neurobiology · doi:10.1016/b978-0-12-411546-0.00014-7 · Cited by 30
Amphetamine‐induced chorea in attention deficit–hyperactivity disorder
Morgan, J. C., Winter, W. C., & Wooten, G. F. (2004) · Movement Disorders · doi:10.1002/mds.20081 · Cited by 32
Banaschewski, T., Coghill, D., Santosh, P., Zuddas, A., Asherson, P. J., Buitelaar, J. K., Danckaerts, M., Döpfner, M., Faraone, S. V., Rothenberger, A., et al. (2008) · Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie · doi:10.1024/1422-4917.36.2.81 · Cited by 29
ADHD in children and adolescents.
Keen, D. V., & Hadijikoumi, I. (2008) · Europe PMC (PubMed Central) · Cited by 29
The QT interval and psychotropic medications in children
McNally, P., McNicholas, F., & Oslizlok, P. C. (2006) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-006-0573-0 · Cited by 30
Complexities for Assessment and Treatment of Co-Occurring ADHD and Tics
Coffey, B. J. (2015) · Current Developmental Disorders Reports · doi:10.1007/s40474-015-0061-7 · Cited by 28
Amitai, N., Weber, M., Swerdlow, N. R., Sharp, R. F., Breier, M. R., Halberstadt, A. L., & Young, J. W. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.09.007 · Cited by 28
Changing Patterns of Alpha Agonist Medication Use in Children and Adolescents 2009–2011
Fiks, A. G., Mayne, S. L., Song, L., Steffes, J., Liu, W., McCarn, B., Margolis, B., Grimes, A., Gotlieb, E. M., Localio, R., et al. (2015) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2014.0122 · Cited by 28
NTP-CERHR Expert Panel Report on the reproductive and developmental toxicity of methylphenidate
Golub, M. S., Costa, L. G., Crofton, K. M., Frank, D. A., Fried, P. A., Gladen, B. C., Henderson, R. F., Liebelt, E. L., Lusskin, S. I., Marty, S., et al. (2005) · Birth Defects Research Part B Developmental and Reproductive Toxicology · doi:10.1002/bdrb.20049 · Cited by 28
Metadata
- Authors
- The Tourette’s Syndrome Study Group
- Corresponding author
- The Tourette’s Syndrome Study Group
- Venue
- Neurology
- Published
- 2002-02-26
- Volume
- 58
- Issue
- 4
- Pages
- 527-536
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2266471137
- Cited by
- 504
- References
- 40
- Citations by year
- 2026: 13 · 2025: 9 · 2024: 18 · 2023: 15 · 2022: 13 · 2021: 15 · 2020: 14 · 2019: 18 · 2018: 13 · 2017: 14 · 2016: 18 · 2015: 19 · 2014: 17 · 2013: 11 · 2012: 37
- FWCI
- 19.19
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neurology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01ns033654-04)
- National Institute of Neurological Disorders and Stroke (1R01NS33654)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Social Sciences › Psychology › Clinical Psychology › Obsessive-Compulsive Spectrum Disorders
- Social Sciences › Psychology › Developmental and Educational Psychology › Behavioral and Psychological Studies
- Keywords
- attention deficit hyperactivity disorder, Tourette syndrome, tic disorders, methylphenidate, clonidine, combination therapy, impulsivity, hyperactivity, inattention, sedation
- MeSH terms
- Adolescent, Adrenergic alpha-Agonists, Central Nervous System Stimulants, Attention Deficit Disorder with Hyperactivity, Child, Clonidine, Double-Blind Method, Drug Therapy, Combination, Female, Humans, Male, Methylphenidate, Surveys and Questionnaires, Tic Disorders, Confidence Intervals, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review